The to-date largest screening trial, the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS), employing an algorithm incorporating the CA125 profile over time, failed to reduce ovarian cancer mortality (30). This evidence concerns the gene MUC16 and ovarian cancer.